Company Contamac - a leader in the development of special polymers and a major global provider of biocompatible materials useful in ophthalmology for implantation and other medical purposes. The company, founded in 1987, has grown rapidly and has become known worldwide for its thorough research, clear customer focus and consistently superior quality products. In the modern laboratory complex and headquarters located in Sefron Walden near Cambridge, highly skilled and multi-lingual sales and marketing work with the ever-increasing number of consumers around the world, providing them with the latest materials. The company currently produces Contmac over a hundred kinds of excellent materials that meet the requirements for products on the market contact and intraocular lenses. Commitment to innovation and high standards throughout helped the company to maintain a prominent position in the market and increased the company's commitment to the development and introduction of new technologies in the field of ophthalmology.
At the heart of the company Contamac are opportunities for research and development, emphasize our belief in constant development to meet the changing demands of the global market. Success comes as a result of smart investments in the latest technology, thanks to the work of departments dedicated research, development and quality control, ongoing efforts to manage and consistently meet customer needs and deliver the highest quality products that meet the requirements in the field of ophthalmology. Contamac company used its key advantages for the development of biocompatible materials for other markets. Experience of the medical use of plastics has led to research and co-operation in the markets biocompatible medical devices.
In 2002 the company expanded its capacity Contamac enter the global market through the establishment of a subsidiary Contamac US Inc. The company, based in Colorado, went to the North American and Canadian markets contact lenses, making extensive use of the extensive knowledge of the market and permit system.
In May 2004, the company expanded Contamac went out into adjacent markets through the acquisition of Opteq BV, manufacturer of high-precision devices. Company Contamac BV uses the underlying technology of the parent company, providing scope ophthalmology most technically advanced device platforms available today.
Web:contamac.com
